Rayence Co. Ltd (228850) - Total Liabilities

Latest as of December 2025: ₩23.85 Billion KRW ≈ $16.16 Million USD

Based on the latest financial reports, Rayence Co. Ltd (228850) has total liabilities worth ₩23.85 Billion KRW (≈ $16.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 228850 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Rayence Co. Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Rayence Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Rayence Co. Ltd (228850) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Rayence Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Rayence Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Austin Engineering Ltd
AU:ANG
Australia AU$133.20 Million
Skane mollan AB
ST:SKMO
Sweden Skr35.70 Million
Mirae Asset Daewoo Co Ltd
KO:006805
Korea ₩136.81 Trillion
U&I Corporation
KQ:056090
Korea ₩31.20 Billion
Aminologics Co.Ltd
KQ:074430
Korea ₩30.52 Billion
Akin Tekstil AS
IS:ATEKS
Turkey TL1.71 Billion
Evertex Fabrinology Ltd
TW:1470
Taiwan NT$196.08 Million
CENIT Aktiengesellschaft
XETRA:CSH
Germany €112.46 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Rayence Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Rayence Co. Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 14.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rayence Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rayence Co. Ltd (2015–2025)

The table below shows the annual total liabilities of Rayence Co. Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 ₩23.85 Billion
≈ $16.16 Million
-2.84%
2024-12-31 ₩24.55 Billion
≈ $16.64 Million
-33.09%
2023-12-31 ₩36.69 Billion
≈ $24.86 Million
-1.51%
2022-12-31 ₩37.25 Billion
≈ $25.24 Million
-9.63%
2021-12-31 ₩41.22 Billion
≈ $27.94 Million
+12.78%
2020-12-31 ₩36.55 Billion
≈ $24.77 Million
-3.24%
2019-12-31 ₩37.78 Billion
≈ $25.60 Million
+96.06%
2018-12-31 ₩19.27 Billion
≈ $13.06 Million
-2.74%
2017-12-31 ₩19.81 Billion
≈ $13.42 Million
-20.56%
2016-12-31 ₩24.94 Billion
≈ $16.90 Million
-26.79%
2015-12-31 ₩34.06 Billion
≈ $23.08 Million
--

About Rayence Co. Ltd

KQ:228850 Korea Medical Devices
Market Cap
$63.88 Million
₩94.26 Billion KRW
Market Cap Rank
#20874 Global
#1150 in Korea
Share Price
₩5990.00
Change (1 day)
+2.39%
52-Week Range
₩4895.00 - ₩6990.00
All Time High
₩20930.72
About

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more